Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-30 @ 5:05 PM
Study NCT ID:
NCT05165433
Status:
COMPLETED
Last Update Posted:
2025-12-16
First Post:
2021-12-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
Sponsor:
Akamis Bio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-07
First Submit QC Date:
None
Study First Post Date:
2021-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED